We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Stay up to date on the topics that matter to you

Trending News

A scientist in a lab holding up a centrifuge tube.

Materials Follow the “Rule of Four” — But Scientists Don’t Know Why Yet

A white blood cell.

Promising Treatment Approach for Aggressive Leukemia Identified

High magnification micrograph of microglia cells stained with Rio-Hortega's method (silver carbonate). This type is the ramified or resting microglia that appears in normal brain tissue.

Mobilizing Microglia in the Fight Against Alzheimer’s Disease

Nerve Cells in the Human Neocortex Are Wired Differently Than in Mice

Immune Cells “Remember” the Pain of Newborn Injuries

Siblings' Rare Genetic Mutation Offers Clues for Type 1 Diabetes Therapy

News

Domainex Awarded Technology Strategy Board Funding

£250,000 grant to support the development of a new drug for the treatment of cancers.

Research Initiative to Advance Diabetes Care and Treatment

The collaboration between Arizona State University and Pfizer aims to discover molecular markers.

NIH Study Finds Broad Spectrum of Cancer Risk for Organ Transplant Recipients in US

Results of the study published in the Nov. 2, 2011, issue of the Journal of the American Medical Association.

MorphoSys and Shionogi Agree Three-Year Extension of Research Partnership

Shionogi to continue using MorphoSys's HuCAL antibody technology in drug discovery research.

Novacta Announces Initiation of Clinical Studies on NVB302 for C. difficile Infection

First molecule of a novel therapeutic class of lantibiotics commences Phase I trials.

Cobra Biologics Acquires Unitech Pharma Group

Acquisition to expand Cobra’s capacity and biopharmaceutical service offering.

apceth Received Extended Manufacturer's Licence for Somatic Cell Therapeutics at the Ottobrunn Site

Four new cleanrooms expand capacity to a total of 600 m2.

YM BioSciences Nimotuzumab Results Reported at SIOP Conference

Phase II study of nimotuzumab in pediatric patients with recurrent diffuse intrinsic pontine glioma.

Trophos Initiates Phase II Study for Novel Cardioprotective Compound, TRO40303, in Acute MI

European study being performed as part of Trophos-led, EU funded MitoCare project.

Illumina Names Dr. Daniel S. Grosu Chief Medical Officer

As new medical point person for regulators, Grosu to provide medical perspective to project teams, work closely with Illumina clinical services lab.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter